Canada Cardiovascular Devices Market Analysis and Forecasts to 2015

Abstract

Canada Cardiovascular Devices Market Analysis and Forecasts to 2015

Summary

GlobalData’s medical device report: “Canada Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the Canada cardiovascular devices market. The report provides market landscape, competitive landscape and market trends information on seven market categories including cardiac rhythm management, cardiovascular monitoring and diagnostic devices, cardiovascular prosthetic devices, cardiovascular surgery, interventional cardiology, peripheral vascular devices and electrophysiology. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.

Scope

- Forecasts & Analysis of the Canada cardiovascular devices market to 2015.
- Market segmentation by Cardiac Rhythm Management (CRM), Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Interventional Cardiology, Peripheral Vascular Devices and Electrophysiology.
- Market Analysis from 2001 to 2008, including new updated 2008 data.
- Analysis of the leading companies and competitive landscape including 2008 company market share analysis.
- Analysis of key diabetes care pipeline products, new technologies and clinical trials.
- Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.
- Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.

Reasons to buy

- Understand what the new growth opportunities are within the Canada cardiovascular devices market.
- Develop a clear knowledge & understanding of the Canada cardiovascular devices competitor landscape and how this will change to 2015.
- Identify acquisition opportunities across the Canada cardiovascular devices market.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Make more informed business decisions from the insightful and in-depth analysis of the market and the factors shaping it.

Keywords

Canada health structure, drug eluting stent, catheters, tissue valve, mechanical valve, heart valve, cardiac assist, peripheral vascular devices, cardiac rhythm management, pacemakers, implantable defibrillators, average price, market size, competitive analysis, company share, market share, average price, pipeline products, drivers, restraints, volume, Boston Scientific Corporation, Medtronic, Inc., Cordis Corporation, Abbott Laboratories, St. Jude Medical Inc., BIOTRONIK GmbH & Co. KG, Sorin Group Canada, Inc., GE Healthcare, Philips Healthcare, OSI Systems, Inc., Cardiac Science Corporation, Nihon Kohden Corporation, Welch Allyn Inc., Card Guard AG, Edwards Lifesciences Corporation, Thoratec Corporation, Datascope Corporation, Arrow International, Inc., ABIOMED, Inc., MAQUET GmbH & Co. KG, AtriCure, Inc., Terumo Corporation, ev3 Inc., C.R. Bard, Inc., Medical Ventures Corp., Baylis Medical Company Inc., Interface Biologics, Inc., Kardium Inc., CARDIAnove.